Search

Phage Futures 2019 “super early bird pricing” ends today, Nov. 2 (Note: the student rate will still available until Nov. 30). Get 10% off with this code: PHDI10. Also, the organizers just announced that they're accepting poster submissions

Dr. Eleanor Jameson has an opening for a PhD student to study the role of phages in the gut microbiome at the University of Warwick. Apply here!

Benler and colleagues at San Diego State University published a new paper that shows that diversity-generating retroelements (which lead to hypervariable proteins) are present in many prophages found in bacteria that live in the human gut.

Dr. Urmi Bajpai invited phage researchers to join a newly unveiled global research consortium for promoting phage and lysin therapy: the International Bacteriophage Research Consortium. This is a collaboration between Acharya Narendra Dev C

Chen et al. published a groundbreaking new study on the discovery of a new kind of phage transduction that leads to genome hypermobility. You’ve heard of generalized and specialized transduction—now there's "lateral transduction."

Dr. Darren Smith posted a new 24-month postdoc position at Northumbria University in Newcastle upon Tyne, UK. The postdoc will study the ecology and biology of phages in the guts of pre-term infants. Apply by Nov 30, 2018.

Eric Boodman wrote a great article on the background of Adaptive Phage Therapeutics (paywall)

Pherecydes published the long-awaited results of PhagoBurn, the first blinded, controlled, randomized phage trial on burn patients.

AmpliPhi just received positive FDA feedback for phase 2 clinical trials using their phage cocktails against Pseudomonas aeruginosa (AB-PA01) and Staphylococcus aureus (AB-SA01).

Steffanie Strathdee and Urmi S. Bajpai announced a new 12-month postdoc position starting July 2019. The postdoc will work on phages in Dr. Bajpai’s lab at ANDC in Delhi. Contact urmibajpai@andc.du.ac.in to apply (fellowship application dea

Phage Futures (January 29-30, 2019) is a translational phage therapy conference where Steffanie Strathdee, Tom Patterson, the FDA, and others will discuss how we move phage therapy forward in the US. Registration is open to all - use code “

Case report from the Eliava Phage Therapy Center in Tbilisi of a 16-year-old with Netherton syndrome, atopic diathesis and serious staphylococcal infections, with allergy to multiple antibiotics. Treatment with several antistaphylococcal ph

Article by Jean-Paul Pirnay and colleagues in Pharmaceutical Research, published online on 10 November 2010, whose title frames the phage therapy paradigm as a choice between prêt-à-porter (ready-made) and sur-mesure (tailor-made). Pharmace

Pharokka is a Python tool, installable through bioconda, that annotates bacteriophage genomes easily, rapidly and consistently with standards-compliant outputs, taking under 5 minutes for an average 50-kb phage genome. Its authors built it

Nancy Tawil of Qeen Biotechnologies appears in an upcoming report on phage therapy and its potential against antibiotic-resistant infections on Radio-Canada's science programme Découverte. It airs Sunday 8 November 2026 at 6:30 p.m. on ICI

PEPHI (Permanent Phage Infections), an ERC Starting Grant project coordinated by Helmholtz-Zentrum für Infektionsforschung in Germany, runs from 1 March 2027 to 29 February 2032 with an EU contribution of €1,499,982. It tests whether nucleu

PhageScanner is a reconfigurable machine-learning framework for annotating bacteriophage genomic and metagenomic features, including phage virion proteins. PhageScanner: a reconfigurable machine learning framework for bacteriophage genomic

If you are interested in postdoc or PhD opportunities, you are welcome to send your CV to Brouns Lab. Postdoc candidates seeking a host laboratory for a personal fellowship can also get in touch. Brouns Lab

PhageGE is a graphical platform for exploring bacteriophage genomes, with interactive genomic analysis and visualization tools. PhageGE: an interactive web platform for exploratory analysis and visualization of bacteriophage genomes

The study characterizes P9ly, a lytic enzyme from bacteriophage PSD9. In laboratory experiments, it showed bacteriolytic and bactericidal activity against multidrug-resistant Shigella dysenteriae and Staphylococcus aureus strains; combining